New York, NY 23 Sep 2020: The Meningitis Diagnosis and Treatment Market size is anticipated to reach over USD 157.8 million by 2026. In 2017, the bacterial type dominated the global market, in terms of revenue. Asia-Pacific is expected to be the fastest growing contributor to the global market revenue in 2017.
Swelling to the meninges is known as meningitis. Meningitis affects the meninges, the membranes that covers spinal cord and brain that protect the central nervous system (CNS) along with the cerebrospinal fluid. Meningitis can cause by bacteria, fungal and virus. Bacterial infection is the most common meningitis. Some of the bacteria that can cause bacterial meningitis are Group B Streptococcus and Streptococcus pneumoniae (S. pneumoniae). Other types of meningitis are non-infectious meningitis, viral, parasitic, and fungal. However, the bacterial type is the most lethal which is considered as life-threatening type.
Other factors causing meningitis are HIV, tuberculosis, and certain illness. According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV) is major infectious disease. According to the same reports, around 36.7 million people across the globe were living with HIV during 2017. Such high prevalence of transferable illnesses is expected to drive the demand for diagnostic tests. Meningitis diagnostic test are carried out on human samples in order to prevent meningitis and/or diagnose meningitis and regulate drug therapies.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-sample
The industry is segmented on the basis of type, diagnostic test, end user, and geography. Based on type, the market is bacterial, viral and fungal. on the basis of diagnostic tests, the market is segmented into PCR Assay, Lateral Flow Assay, Latex Agglutination Tests, ELISA Tests, and Culture Test. By end user, the market is further bifurcated as hospitals, diagnostic centers and others.
Asia Pacific is estimated to be the fastest growing region in terms of revenue. High occurrence of people suffering from meningitis along with increasing focus early diagnosis and treatment for the disease, provides significant growth opportunities of the market in APAC.
The major key players operating in the meningitis diagnosis and treatment industry include Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Nanosphere (Luminex Corporation), Seegene Inc., Qnostics, ELITechGroup, and Abbott Laboratories. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.
To get Incredible Discounts on this Premium Report, Click At : https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Polaris Market Research
Email: [email protected]